Coltorti M, Romano M, Persico M, Morisco F, Tuccillo C, Caporaso N
Istituto di Medicina Generale e Metodologia Clinica, First Medical School, University of Naples, Italy.
Infection. 1995 Jan-Feb;23(1):33-6. doi: 10.1007/BF01710055.
This study was designed to evaluate serum HCV-RNA, liver histology, and RIBA-II pattern in asymptomatic anti-HCV positive subjects with persistently normal or slightly (i.e. < or = 1.5 times the upper limit of the normal range) elevated serum ALT levels. To this purpose, 22 asymptomatic anti-HCV positive subjects (11 men and 11 women, median age 40, range 21-70 years) underwent liver biopsy and determination of serum HCV-RNA. Positivity for anti-HCV was determined by ELISA-2 and by RIBA-II. Serum HCV-RNA was determined by PCR. Our data show that: 1) 9/22 symptom-free, anti-HCV positive subjects had histological features of chronic liver disease associated with ongoing HCV infection; 2) four subjects had no histological signs of chronic hepatitis and normal serum ALT levels despite positivity for serum HCV-RNA; 3) serum ALT levels did not discriminate HCV-RNA positive subjects with from those without chronic hepatitis; 4) in anti-HCV positive subjects with normal serum ALT levels, a positive RIBA-II pattern was not always predictive of HCV viraemia or chronic hepatitis while an indeterminate RIBA-II pattern was frequently associated with nonspecific liver changes or normal histology. In conclusion, based on these findings, "true" healthy carriers of HCV (i.e. subjects with normal serum ALT levels and no histological features of chronic hepatitis despite HCV viraemia) may exist.
本研究旨在评估血清丙型肝炎病毒核糖核酸(HCV-RNA)、肝脏组织学以及重组免疫印迹分析-II(RIBA-II)模式,研究对象为血清丙氨酸氨基转移酶(ALT)水平持续正常或轻度升高(即≤正常范围上限的1.5倍)的无症状抗HCV阳性受试者。为此,22名无症状抗HCV阳性受试者(11名男性和11名女性,年龄中位数40岁,范围21 - 70岁)接受了肝活检及血清HCV-RNA检测。抗HCV阳性通过酶联免疫吸附测定-2(ELISA-2)和RIBA-II确定。血清HCV-RNA通过聚合酶链反应(PCR)测定。我们的数据显示:1)22名无症状抗HCV阳性受试者中,9名具有与持续性HCV感染相关的慢性肝病组织学特征;2)4名受试者尽管血清HCV-RNA呈阳性,但无慢性肝炎的组织学迹象且血清ALT水平正常;3)血清ALT水平无法区分HCV-RNA阳性且患有慢性肝炎的受试者与未患慢性肝炎的受试者;4)在血清ALT水平正常的抗HCV阳性受试者中,RIBA-II模式呈阳性并不总是预示着HCV病毒血症或慢性肝炎,而RIBA-II模式不确定则常与非特异性肝脏改变或组织学正常相关。总之,基于这些发现,可能存在HCV的“真正”健康携带者(即血清ALT水平正常且尽管存在HCV病毒血症但无慢性肝炎组织学特征的受试者)。